Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Berger

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Neurosciences Research Program Bulletin|December 1, 1978
Investigating the role of endogenous opioid peptides in psychiatric disordersP A Berger
Bulletin of the Menninger Clinic|May 1, 1987
Pharmacological treatment for borderline personality disorderP A Berger
Science (New York, N.Y.)|May 26, 1978
Medical treatment of mental illnessP A Berger
The Journal of Nervous and Mental Disease|February 1, 1981
Biochemistry and the schizophrenia. Old concepts and new hypothesisP A Berger
Psychopharmacology Bulletin|October 1, 1980
Opioid neuropeptides in psychiatric disordersP A Berger
The Journal of Nervous and Mental Disease|April 1, 1977
Narcolepsy, paranoid psychosis, and tardive dyskinesia: a pharmacological dilemmaA Pfefferbaum, P A Berger
The American Journal of Psychiatry|August 1, 1980
Correlation of cerebrospinal fluid lactate with ageJ Yesavage, P A Berger
Schizophrenia Bulletin|January 1, 1980
Tardive dyskinesia: clinical, biological, and pharmacological perspectivesP A Berger, K Rexroth
Biological Psychiatry|September 1, 1982
Neuroleptic effects in Tourette syndrome predict dopamine excess and acetylcholine deficiencyS M Stahl, P A Berger
Lancet (London, England)|October 3, 1981
Bromocriptine in dystoniaS M Stahl, P A Berger
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Neurosciences Research Program Bulletin|December 1, 1978
Investigating the role of endogenous opioid peptides in psychiatric disordersP A Berger
Bulletin of the Menninger Clinic|May 1, 1987
Pharmacological treatment for borderline personality disorderP A Berger
Science (New York, N.Y.)|May 26, 1978
Medical treatment of mental illnessP A Berger
The Journal of Nervous and Mental Disease|February 1, 1981
Biochemistry and the schizophrenia. Old concepts and new hypothesisP A Berger
Psychopharmacology Bulletin|October 1, 1980
Opioid neuropeptides in psychiatric disordersP A Berger
The Journal of Nervous and Mental Disease|April 1, 1977
Narcolepsy, paranoid psychosis, and tardive dyskinesia: a pharmacological dilemmaA Pfefferbaum, P A Berger
The American Journal of Psychiatry|August 1, 1980
Correlation of cerebrospinal fluid lactate with ageJ Yesavage, P A Berger
Schizophrenia Bulletin|January 1, 1980
Tardive dyskinesia: clinical, biological, and pharmacological perspectivesP A Berger, K Rexroth
Biological Psychiatry|September 1, 1982
Neuroleptic effects in Tourette syndrome predict dopamine excess and acetylcholine deficiencyS M Stahl, P A Berger
Lancet (London, England)|October 3, 1981
Bromocriptine in dystoniaS M Stahl, P A Berger
Pageof 14